Vancomycin Taper to Prevent Recurrent Clostridioides Difficile
Vancomycin Taper to Prevent Recurrent Clostridioides Difficile
Recruiting · NCT07328971 · Registry updated 2026-09-23Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Vancomycin Taper to Prevent Recurrent Clostridioides Difficile | Bacterial Infections and Mycoses, Clostridium difficile colitis, Clostridium infectious disease, Digestive System Diseases, Infections, bacterial infectious disease, digestive system disorder, enterocolitis, gastroenteritis, gram-positive bacterial infections, intestinal disorder | Recruiting | Phase 3 | 2026-09-23 | NCT07328971 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| McGill University Health Centre/Research Institute of the McGill University Health Centre | 139 |
2 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| McGill University Health Centre | Montreal | Canada | 1 |
| University of Alberta | Edmonton | Canada | 23 |